PTEN is known to bind phospholipid membranes in vitro via its C2-domain and mutation of basic residues in this region reduces PTEN's membrane affinity and its ability to suppress growth of glioblastoma tumor cells [11]. This evidence concerns the gene PTEN and neoplasm.